Poolbeg Pharma PLC (AIM:POLB) (OTCQB:POLBF) CEO, Jeremy Skillington presents at the Proactive One2One Investor Forum – October 6th 2022

Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a unique capital light clinical model which aims to develop multiple products faster and more cost effectively than the conventional biotech model.

source

Leave a Reply

Your email address will not be published. Required fields are marked *